Earnings Feed
Start Free
|S-1/AMar 22, 5:27 PM ET

Lirum Therapeutics, Inc. S-1/A

S-1/A · Lirum Therapeutics, Inc. · Filed Mar 22, 2024

Documents

20 files
  • S-1
    tm2319041-8_s1a.htm

    S-1/A

  • EX-1.1
    tm2319041d10_ex1-1.htm

    EXHIBIT 1.1

  • EX-4.2
    tm2319041d10_ex4-2.htm

    EXHIBIT 4.2

  • EX-23.1
    tm2319041_ex23-1.htm

    EXHIBIT 23.1

  • GRAPHIC
    fc_aberrant-4c.jpg

    GRAPHIC

  • GRAPHIC
    fc_condition-4clr.jpg

    GRAPHIC

  • GRAPHIC
    fc_precision-4c.jpg

    GRAPHIC

  • GRAPHIC
    fc_program-4c.jpg

    GRAPHIC

  • GRAPHIC
    lc_efficacy-4clr.jpg

    GRAPHIC

  • GRAPHIC
    lc_ewing-4clr.jpg

    GRAPHIC

  • GRAPHIC
    lg_lirum-4clr.jpg

    GRAPHIC

  • GRAPHIC
    tb_approach-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_cancer-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_dose-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_historical-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_igf-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_lirumapproach-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_preclinical-4clr.jpg

    GRAPHIC

  • GRAPHIC
    tb_tumortype-4c.jpg

    GRAPHIC

  • GRAPHIC
    tb_uniquely-4c.jpg

    GRAPHIC